VIVE News and Press, Viveve Medical Inc. From 11/11/21

Viveve Medical (NASDAQ:VIVE): Q3 GAAP EPS of -$0.67 misses by $0.10. Revenue of $1.6M (+5.3% Y/Y) misses by $0.09M. Press Release For further details see: Viveve Medical EPS misses by $0.10, misses on revenue

Total revenue of $1.6M reported for Q3 Pivotal SUI PURSUIT trial enrollment nears completion - randomizations on-track for completion in Q4 ENGLEWOOD, CO / ACCESSWIRE / November 11, 2021 / Viveve Medical, Inc. (NASDAQ:VIVE), a medical technology company focused on women's intimat...

Viveve Medical (NASDAQ:VIVE) is scheduled to announce Q3 earnings results on Thursday, November 11th, after market close. The consensus EPS Estimate is -$0.57 (-119.2% Y/Y) and the consensus Revenue Estimate is $1.69M (+11.2% Y/Y). Over the last 3 months, EPS estimates have seen 1 upward revi...

ENGLEWOOD, CO / ACCESSWIRE / November 2, 2021 / Viveve Medical, Inc. (NASDAQ:VIVE), a medical technology company focused on women's intimate health, today announced that it will report its third quarter 2021 financial results and provide a corporate update after the close of the U.S. financi...

Issuance further expands and strengthens Company's intellectual property portfolio ENGLEWOOD, CO / ACCESSWIRE / October 28, 2021 / Viveve Medical, Inc. (NASDAQ:VIVE), a medical technology company focused on women's intimate health, today announced that the United States Patent and Trade...

Patent strengthens and expands Viveve's intellectual property portfolio for the treatment of stress urinary incontinence ENGLEWOOD, CO / ACCESSWIRE / September 23, 2021 / Viveve Medical, Inc. (NASDAQ:VIVE), a medical technology company focused on women's intimate health, today announced...

3 Biotech Penny Stocks You Should Know About Right Now While the broader stock market is down today, there are plenty of penny stocks that are pushing up right now. And, over the past few months, many investors have been focused on biotech penny stocks . There are a few good reasons...

Gainers: ZIVO Bioscience (NASDAQ:ZIVO) +98%. Edesa (NASDAQ:EDSA) +68%. Sentage (NASDAQ:SNTG) +21%. Viveve (NASDAQ:VIVE) +19%. Aterian (NASDAQ:ATER) +15%. Atea Pharmaceuticals (NASDAQ:AVIR) +12%. Corvus (NASDAQ:CRVS) +13%. Five Star (NASDAQ:FVE) +12%. BEST (NYSE:BEST) +10%. Petros Pharmaceutic...

Gainers: ZIVO Bioscience (NASDAQ:ZIVO) +155%, Edesa Biotech (NASDAQ:EDSA) +34%, Atea Pharmaceuticals (NASDAQ:AVIR) +20%, Synlogic (NASDAQ:SYBX) +13%, Viveve Medical (NASDAQ:VIVE) +9%. Losers: BeyondSpring (NASDAQ:BYSI) -22%, Protagonist Therap...

ENGLEWOOD, CO / ACCESSWIRE / September 7, 2021 / Viveve Medical, Inc. (NASDAQ:VIVE), a medical technology company focused on women's intimate health, today announced that Scott Durbin, chief executive officer, will participate in the H.C. Wainwright 23 rd Annual Global Investment Conference...